- AEM (SGX:AWX) said it reached a settlement over a confidential arbitration with Advantest for US$20m. This should be a positive for AEM as there will no longer be other payments relating to this matter in the future and this will enable AEM to operate and market its new generation of active thermos interposer without any hindrance.
- - Read this at SGinvestors.io -
Settlement to hit FY23 earnings
- - Read this at SGinvestors.io -
- We believe that this settlement will further cement AEM’s place as a leader in the active thermo interposer segment and that designs of new generation circuits etc will be all owned by AEM and won’t have any contest by Advantest which will be positive for AEM’s prospects.
2Q23E should be dismal and a weaker FY23E
- Read more at SGinvestors.io.